149 related articles for article (PubMed ID: 24945792)
1. The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats.
Nickel S; Mahringer A
Xenobiotica; 2014 Nov; 44(11):1046-54. PubMed ID: 24945792
[TBL] [Abstract][Full Text] [Related]
2. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.
Mahringer A; Fricker G
Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085
[TBL] [Abstract][Full Text] [Related]
3. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.
Hartz AM; Mahringer A; Miller DS; Bauer B
J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
Hartz AM; Madole EK; Miller DS; Bauer B
J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386
[TBL] [Abstract][Full Text] [Related]
5. Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP).
Engdahl E; van Schijndel MDM; Voulgaris D; Di Criscio M; Ramsbottom KA; Rigden DJ; Herland A; Rüegg J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073890
[TBL] [Abstract][Full Text] [Related]
6. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of estrogen receptor genes in Gobiocypris rarus and their expression upon endocrine disrupting chemicals exposure in juveniles.
Wang H; Wang J; Wu T; Qin F; Hu X; Wang L; Wang Z
Aquat Toxicol; 2011 Jan; 101(1):276-87. PubMed ID: 21111493
[TBL] [Abstract][Full Text] [Related]
8. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human liver drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1072-82. PubMed ID: 20360302
[TBL] [Abstract][Full Text] [Related]
9. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
10. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.
More VR; Campos CR; Evans RA; Oliver KD; Chan GN; Miller DS; Cannon RE
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1199-1212. PubMed ID: 27193034
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
Harati R; Benech H; Villégier AS; Mabondzo A
Mol Pharm; 2013 May; 10(5):1566-80. PubMed ID: 22998451
[TBL] [Abstract][Full Text] [Related]
12. Repeated Exposure to 4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP), an Active Metabolite of Bisphenol A, Aggressively Stimulates Breast Cancer Cell Growth in an Estrogen Receptor
Hirao-Suzuki M; Takeda S; Okuda K; Takiguchi M; Yoshihara S
Mol Pharmacol; 2019 Mar; 95(3):260-268. PubMed ID: 30552153
[TBL] [Abstract][Full Text] [Related]
13. Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation.
Li Y; Zhang J; Xu P; Sun B; Zhong Z; Liu C; Ling Z; Chen Y; Shu N; Zhao K; Liu L; Liu X
J Neurochem; 2016 Jul; 138(2):282-94. PubMed ID: 27168176
[TBL] [Abstract][Full Text] [Related]
14. [¹¹C]befloxatone brain kinetics is not influenced by Bcrp function at the blood-brain barrier: a PET study using Bcrp TGEM knockout rats.
Hosten B; Boisgard R; Jacob A; Goutal S; Saubaméa B; Dollé F; Scherrmann JM; Cisternino S; Tournier N
Eur J Pharm Sci; 2013 Nov; 50(3-4):520-5. PubMed ID: 23981334
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
Harati R; Villégier AS; Banks WA; Mabondzo A
J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
[TBL] [Abstract][Full Text] [Related]
16. Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries.
Salvamoser JD; Avemary J; Luna-Munguia H; Pascher B; Getzinger T; Pieper T; Kudernatsch M; Kluger G; Potschka H
Mol Pharm; 2015 Jun; 12(6):2049-60. PubMed ID: 25898179
[TBL] [Abstract][Full Text] [Related]
17. Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment.
Mazur CS; Marchitti SA; Dimova M; Kenneke JF; Lumen A; Fisher J
Toxicol Sci; 2012 Aug; 128(2):317-25. PubMed ID: 22552776
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
Reichel V; Burghard S; John I; Huber O
Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate.
Kodaira H; Kusuhara H; Fujita T; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2011 Dec; 339(3):935-44. PubMed ID: 21934030
[TBL] [Abstract][Full Text] [Related]
20. Effects of 17beta-estradiol and xenoestrogens on the neuronal survival in an organotypic hippocampal culture.
Sato K; Matsuki N; Ohno Y; Nakazawa K
Neuroendocrinology; 2002 Oct; 76(4):223-34. PubMed ID: 12411739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
